(NP -LCB-/-LRB- (NP-COOD (NP (NP Changes/NNS) (PP in/IN (NP (NP leucocytic/JJ estrogen/NN receptor/NN levels/NNS) (PP in/IN (NP (NP patients/NNS) (PP with/IN (NP climacteric/JJ syndrome/NN))))))) and/CC (NP (NP therapeutic/JJ effect/NN) (PP of/IN (NP liuwei/FW dihuang/FW pills/NNS)))) -RCB-/-RRB-)
(S (NP-SBJ-24 (NP The/DT numbers/NNS) (PP of/IN (NP (NP (NP estrogen/NN receptor/NN) (PRN -LRB-/-LRB- (NP ER/NN) -RRB-/-RRB-)) (PP in/IN (NP (NP human/JJ peripheral/JJ leucocytes/NNS) (PP in/IN (NP (NP 22/CD women/NNS) (PP with/IN (NP climacteric/JJ syndrome/NN))))))))) (VP were/VBD (VP measured/VBN (NP *-24/-NONE-) (PP by/IN (NP radioligand/NN method/NN)))) ./.)
(S (NP-SBJ-25 The/DT results/NNS) (VP were/VBD (VP compared/VBN (NP *-25/-NONE-) (PP with/IN (NP (NP those/DT) (PP of/IN (NP 12/CD normal/JJ child-bearing-age/JJ women/NNS)))))) ./.)
(S (NP-SBJ It/PRP) (VP wat/VBD (VP found/VBN (SBAR that/IN (S (NP-SBJ (NP the/DT contents/NNS) (PP of/IN (NP (NP leucocytic/JJ ER/NN) (PP in/IN (NP climacteric/JJ syndrome/NN patients/NNS))))) (VP were/VBD (ADJP-PRD (ADJP significantly/RB lower/JJR) (PP than/IN (NP normal/JJ child-bearing-age/JJ women/NNS)))))))) ./.)
(S (NP-SBJ-26 The/DT authors/NNS) (VP used/VBD (NP (NP a/DT Chinese/JJ prescription/NN) --/: (NP (NP Liuwei/FW Dihuang/FW Pills/NNS) (PRN -LRB-/-LRB- (NP LDP/NN) -RRB-/-RRB-))) (S (NP-SBJ *-26/-NONE-) (VP to/TO (VP treat/VB (NP the/DT patients/NNS) (PP-TMP for/IN (NP 2/CD months/NNS)))))) ./.)
(S (NP-SBJ-27 (NP The/DT numbers/NNS) (PP of/IN (NP leucocytic/JJ ER/NN))) (VP were/VBD (ADVP significantly/RB) (VP increased/VBN (NP *-27/-NONE-) (PP-TMP after/IN (NP treatment/NN)))) ./.)
(S (NP-SBJ The/DT data/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ (NP decrease/NN) (PP of/IN (NP (NP ER/NN levels/NNS) (PP in/IN (NP cell/NN))))) (VP may/MD (VP involve/VB (PP in/IN (NP (NP the/DT pathogenesis/NN) (PP of/IN (NP climacteric/JJ syndrome/NN))))))))) ./.)
(S (NP-SBJ LDP/NN) (VP-COOD (CONJP not/RB only/RB) (VP increases/VBZ (NP plasma/NN estradiol/NN levels/NNS)) ,/, (CONJP but/CC also/RB) (VP increases/VBZ (NP the/DT leucocytic/JJ ER/NN levels/NNS))) ./.)
(S (NP-SBJ This/DT) (VP may/MD (VP be/VB (NP-PRD (NP the/DT basis/NN) (PP of/IN (NP (NP the/DT therapeutic/JJ effect/NN) (PP on/IN (NP the/DT disease/NN))))))) ./.)
